Neoplasm: Clinical Trials

5 trials for Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5

Follow Neoplasm: new trials by email Literature Review of Neoplasm trials Research Report on Neoplasm

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban
rivaroxaban, Low-molecular-weight heparin - Neoplasm, Venous Thromboembolism
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1592016-09-012018-08-13
Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide
Polihexanide 2%, Metronidazole 0.8% - Neoplasm, Wounds and Injuries
Phase 3CompletedUniversity of Sao Paulo242013-09-012015-09-02
Iressa Expanded Access Program (EAP)
ZD1839 (Gefitinib) - Carcinoma, Non-small-cell Lung
Phase 3CompletedAstraZeneca2000-08-012013-01-04
Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy
Epoetin alfa - Anemia, Cancer
Phase 3CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.3751996-08-012011-05-18
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy
epoetin alfa - Anemia, Multiple Myeloma
Phase 3CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.2011995-02-012011-05-18

Narrower conditions

Neoplasms (5)  ·  Anemia (2)  ·  Breast Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Esophageal Neoplasms (1)  ·  Lymphoma (1)  ·  Multiple Myeloma (1)  ·  Neoplasm Metastasis (1)  ·  Ovarian Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Small Cell Lung Carcinoma (1)  ·  Venous Thromboembolism (1)  ·  Wounds and Injuries (1)

Broader conditions

Bronchial Neoplasms (2)  ·  Carcinoma, Bronchogenic (2)  ·  Cardiovascular Diseases (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Lung Diseases (2)  ·  Lung Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Neoplasms (2)  ·  Thoracic Neoplasms (2)  ·  Vascular Diseases (2)  ·  Adnexal Diseases (1)  ·  Blood Protein Disorders (1)

Interventions

Epoetin Alfa (2)  ·  Dalteparin (1)  ·  Gefitinib (1)  ·  Heparin, Low-Molecular-Weight (1)  ·  Rivaroxaban (1)

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  AstraZeneca (1)  ·  University of Sao Paulo (1)

Countries

Brazil (1)  ·  France (1)  ·  United States (1)

Top investigators

Guy Meyer, MD (1)

Results publications

PMID 34172290, PMID 34627853